Christopher Yea Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Yea.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Yea. Christopher Yea is a Chief Development Officer in KalVista Pharmaceuticals, Inc. ($CBYL).
Address: C/O KALVISTA PHARMACEUTICALS, INC. BLDG. 227, TETRICUS SCIENCE PARK SALISBURY, WILTSHIRE SP4 0JQUnited Kingdom
Companies in which Christopher Yea is an Insider
KalVista Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Yea: Chief Development Officer
Holdings: 42,969 shares
Latest Transaction: May 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Yea
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 24.84 | 5,000 | 124,197 | 42,969 | 48 K to 43 K (-10.42 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 31.87 | 500 | 15,933 | 47,969 | 48.5 K to 48 K (-1.03 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 32.94 | 3,311 | 109,059 | 48,469 | 51.8 K to 48.5 K (-6.39 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 33.74 | 10,389 | 350,572 | 51,780 | 62.2 K to 51.8 K (-16.71 %) |
| Feb 25 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Sell | S | 35.39 | 800 | 28,314 | 62,169 | 63 K to 62.2 K (-1.27 %) |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 10.20 | 20,000 | 204,000 | 20,000 | |
| Feb 08 2021 | KALV | KalVista Pharmaceu ... | Yea Christopher | Chief Development O ... | Option Exercise | A | 24.23 | 31,000 | 751,130 | 31,000 |